Works by Woodward, Mark


Results: 389
    1
    2
    3
    4
    5

    Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.

    Published in:
    2021
    By:
    • Pinho-Gomes, Ana-Catarina;
    • Azevedo, Luis;
    • Copland, Emma;
    • Canoy, Dexter;
    • Nazarzadeh, Milad;
    • Ramakrishnan, Rema;
    • Berge, Eivind;
    • Sundström, Johan;
    • Kotecha, Dipak;
    • Woodward, Mark;
    • Teo, Koon;
    • Davis, Barry R.;
    • Chalmers, John;
    • Pepine, Carl J.;
    • Rahimi, Kazem;
    • Blood Pressure Lowering Treatment Trialists’ Collaboration
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11

    Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2229, doi. 10.1111/dom.15531
    By:
    • Helmink, Marga A. G.;
    • Hageman, Steven H. J.;
    • Eliasson, Björn;
    • Sattar, Naveed;
    • Visseren, Frank L. J.;
    • Dorresteijn, Jannick A. N.;
    • Harris, Katie;
    • Peters, Sanne A. E.;
    • Woodward, Mark;
    • Szentkúti, Péter;
    • Højlund, Kurt;
    • Henriksen, Jan Erik;
    • Sørensen, Henrik Toft;
    • Serné, Erik H.;
    • van Sloten, Thomas T.;
    • Thomsen, Reimar W.;
    • Westerink, Jan
    Publication type:
    Article
    12

    Cover Image, Volume 23, Issue 8.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1, doi. 10.1111/dom.14493
    By:
    • Gong, Jessica;
    • Harris, Katie;
    • Hackett, Maree;
    • Peters, Sanne A. E.;
    • Brodaty, Henry;
    • Cooper, Mark;
    • Hamet, Pavel;
    • Harrap, Stephen;
    • Mancia, Giuseppe;
    • MacMahon, Stephen;
    • Chalmers, John;
    • Woodward, Mark
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.

    Published in:
    European Journal of Preventive Cardiology, 2024, v. 31, n. 14, p. 1671, doi. 10.1093/eurjpc/zwae096
    By:
    • Helmink, Marga A G;
    • Peters, Sanne A E;
    • Westerink, Jan;
    • Harris, Katie;
    • Tillmann, Taavi;
    • Woodward, Mark;
    • Sloten, Thomas T van;
    • Meer, Manon G van der;
    • Teraa, Martin;
    • Dorresteijn, Jannick A N;
    • Ruigrok, Ynte M;
    • Visseren, Frank L J;
    • Hageman, Steven H J;
    • group, the UCC-SMART study
    Publication type:
    Article
    25
    26
    27
    28
    29

    Marijuana use and car crash injury.

    Published in:
    Addiction, 2005, v. 100, n. 5, p. 605, doi. 10.1111/j.1360-0443.2005.01100.x
    By:
    • Blows, Stephanie;
    • Ivers, Rebecca Q.;
    • Connor, Jennie;
    • Ameratunga, Shanthi;
    • Woodward, Mark;
    • Norton, Robyn
    Publication type:
    Article
    30
    31

    Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease: A Systematic Review and Retrospective Individual Participant–Level Meta-analysis of Clinical Trials.

    Published in:
    Annals of Internal Medicine, 2024, v. 177, n. 7, p. 953, doi. 10.7326/M23-3236
    By:
    • Ku, Elaine;
    • Inker, Lesley A.;
    • Tighiouart, Hocine;
    • McCulloch, Charles E.;
    • Adingwupu, Ogechi M.;
    • Greene, Tom;
    • Estacio, Raymond O.;
    • Woodward, Mark;
    • de Zeeuw, Dick;
    • Lewis, Julia B.;
    • Hannedouche, Thierry;
    • Jafar, Tazeen H.;
    • Imai, Enyu;
    • Remuzzi, Giuseppe;
    • Heerspink, Hiddo J.L.;
    • Hou, Fan Fan;
    • Toto, Robert D.;
    • Li, Philip K.;
    • Sarnak, Mark J.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease.

    Published in:
    International Journal of Environmental Research & Public Health, 2022, v. 19, n. 17, p. 10761, doi. 10.3390/ijerph191710761
    By:
    • Tu, Qiang;
    • Hyun, Karice;
    • Hafiz, Nashid;
    • Knight, Andrew;
    • Hespe, Charlotte;
    • Chow, Clara K.;
    • Briffa, Tom;
    • Gallagher, Robyn;
    • Reid, Christopher M.;
    • Hare, David L.;
    • Zwar, Nicholas;
    • Woodward, Mark;
    • Jan, Stephen;
    • Atkins, Emily R.;
    • Laba, Tracey-Lea;
    • Halcomb, Elizabeth;
    • Usherwood, Tim;
    • Billot, Laurent;
    • Redfern, Julie
    Publication type:
    Article
    38
    41
    42
    43
    44
    45
    46
    47

    CONVINCE in the context of existing evidence on haemodiafiltration.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1006, doi. 10.1093/ndt/gfac019
    By:
    • Vernooij, Robin W M;
    • Bots, Michiel L;
    • Strippoli, Giovanni F M;
    • Canaud, Bernard;
    • Cromm, Krister;
    • Woodward, Mark;
    • Blankestijn, Peter J;
    • committee, CONVINCE scientific
    Publication type:
    Article
    48
    49
    50

    Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.

    Published in:
    Nephrology Dialysis Transplantation, 2016, v. 31, n. 6, p. 978, doi. 10.1093/ndt/gfv349
    By:
    • Peters, Sanne A. E.;
    • Bots, Michiel L.;
    • Canaud, Bernard;
    • Davenport, Andrew;
    • Grooteman, Muriel P. C.;
    • Kircelli, Fatih;
    • Locatelli, Francesco;
    • Maduell, Francisco;
    • Morena, Marion;
    • Nubé, Menso J.;
    • Ok, Ercan;
    • Torres, Ferran;
    • Woodward, Mark;
    • Blankestijn, Peter J.
    Publication type:
    Article